Cardinal Health, Inc. (NYSE:CAH) Shares Bought by Kingsview Wealth Management LLC

Kingsview Wealth Management LLC increased its holdings in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 97.1% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,456 shares of the company's stock after purchasing an additional 2,195 shares during the period. Kingsview Wealth Management LLC's holdings in Cardinal Health were worth $614,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Norges Bank acquired a new stake in shares of Cardinal Health during the 4th quarter worth $246,748,000. Marshall Wace LLP increased its holdings in shares of Cardinal Health by 154.6% during the 4th quarter. Marshall Wace LLP now owns 3,151,736 shares of the company's stock worth $372,756,000 after buying an additional 1,913,892 shares during the last quarter. Castlekeep Investment Advisors LLC acquired a new stake in shares of Cardinal Health during the 4th quarter worth $141,963,000. GAMMA Investing LLC increased its holdings in shares of Cardinal Health by 17,589.1% during the 1st quarter. GAMMA Investing LLC now owns 964,941 shares of the company's stock worth $132,940,000 after buying an additional 959,486 shares during the last quarter. Finally, Junto Capital Management LP acquired a new stake in shares of Cardinal Health during the 4th quarter worth $92,811,000. Hedge funds and other institutional investors own 87.17% of the company's stock.

Cardinal Health Trading Up 0.1%

NYSE:CAH traded up $0.16 on Friday, reaching $158.44. The stock had a trading volume of 153,986 shares, compared to its average volume of 2,392,260. The company has a 50-day moving average of $159.37 and a 200 day moving average of $141.27. The stock has a market cap of $37.82 billion, a P/E ratio of 24.71, a price-to-earnings-growth ratio of 1.56 and a beta of 0.68. Cardinal Health, Inc. has a 12-month low of $96.05 and a 12-month high of $168.44.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The company reported $2.35 earnings per share for the quarter, beating analysts' consensus estimates of $2.15 by $0.20. Cardinal Health had a net margin of 0.70% and a negative return on equity of 68.84%. The company had revenue of $54.88 billion during the quarter, compared to analysts' expectations of $55.33 billion. During the same period in the prior year, the company posted $2.08 EPS. The firm's revenue for the quarter was up .0% on a year-over-year basis. On average, equities analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st were issued a $0.5107 dividend. The ex-dividend date was Tuesday, July 1st. This represents a $2.04 dividend on an annualized basis and a yield of 1.29%. This is a boost from Cardinal Health's previous quarterly dividend of $0.51. Cardinal Health's dividend payout ratio (DPR) is currently 31.83%.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on CAH. Wall Street Zen upgraded Cardinal Health from a "buy" rating to a "strong-buy" rating in a report on Monday, May 5th. UBS Group boosted their price objective on Cardinal Health from $150.00 to $160.00 and gave the stock a "buy" rating in a research note on Tuesday, April 29th. Robert W. Baird boosted their price objective on Cardinal Health from $156.00 to $170.00 and gave the stock an "outperform" rating in a research note on Friday, May 2nd. Wells Fargo & Company upgraded Cardinal Health from an "equal weight" rating to an "overweight" rating and boosted their price objective for the stock from $136.00 to $179.00 in a research note on Tuesday, June 3rd. Finally, Evercore ISI restated an "outperform" rating and set a $180.00 price objective (up previously from $175.00) on shares of Cardinal Health in a research note on Thursday, June 12th. Three equities research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $158.07.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.